1735 related articles for article (PubMed ID: 30687323)
1. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
2. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
Moorman CD; Bastian AG; DeOca KB; Mannie MD
J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
[TBL] [Abstract][Full Text] [Related]
3. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.
Islam SM; Curtis AD; Taslim N; Wilkinson DS; Mannie MD
J Immunol; 2014 Sep; 193(5):2317-29. PubMed ID: 25049359
[TBL] [Abstract][Full Text] [Related]
5. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
6. Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).
Abbott DJ; Blanchfield JL; Martinson DA; Russell SC; Taslim N; Curtis AD; Mannie MD
BMC Immunol; 2011 Dec; 12():72. PubMed ID: 22208499
[TBL] [Abstract][Full Text] [Related]
7. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
[TBL] [Abstract][Full Text] [Related]
8. A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.
Blanchfield JL; Mannie MD
J Leukoc Biol; 2010 Mar; 87(3):509-21. PubMed ID: 20007248
[TBL] [Abstract][Full Text] [Related]
9. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract][Full Text] [Related]
10. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
Carrier Y; Yuan J; Kuchroo VK; Weiner HL
J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
[TBL] [Abstract][Full Text] [Related]
11. Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25
Wilkinson DS; Ghosh D; Nickle RA; Moorman CD; Mannie MD
Front Immunol; 2017; 8():1782. PubMed ID: 29312311
[TBL] [Abstract][Full Text] [Related]
12. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
13. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
[TBL] [Abstract][Full Text] [Related]
14. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3
Mannie MD; DeOca KB; Bastian AG; Moorman CD
Cell Immunol; 2020 Sep; 355():104173. PubMed ID: 32712270
[TBL] [Abstract][Full Text] [Related]
15. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
[TBL] [Abstract][Full Text] [Related]
16. Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Fissolo N; Costa C; Nurtdinov RN; Bustamante MF; Llombart V; Mansilla MJ; Espejo C; Montalban X; Comabella M
J Neuroinflammation; 2012 Jun; 9():139. PubMed ID: 22727044
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
Vandenbark AA; Culbertson NE; Bartholomew RM; Huan J; Agotsch M; LaTocha D; Yadav V; Mass M; Whitham R; Lovera J; Milano J; Theofan G; Chou YK; Offner H; Bourdette DN
Immunology; 2008 Jan; 123(1):66-78. PubMed ID: 17944900
[TBL] [Abstract][Full Text] [Related]
19. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
20. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.
Blanchfield L; Sabatino JJ; Lawrence L; Evavold BD
J Immunol; 2017 Oct; 199(8):2680-2691. PubMed ID: 28887429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
